1.18

0.00% 0.00

Bionano Genomics Inc (BNGO)

Overview News Price History Option Chain Financials Why BNGO Down? Discussions Forecast Stock Split

Bionano Genomics Inc stock is traded at $1.18, with a volume of 83,560. It is up +0.00% in the last 24 hours and up +2.61% over the past month. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Previous Close:

$1.18

Open:

$1.18

24h Volume:

83,560

Relative Volume:

0.60

Market Cap:

$13.54M

Revenue:

$28.74M

Net Income/Loss:

$-31.60M

P/E Ratio:

-0.2323

EPS:

-5.0805

Net Cash Flow:

$-19.30M

1W Performance:

+1.72%

1M Performance:

+2.61%

6M Performance:

+7.27%

1Y Performance:

-63.24%

1-Day Range:

$1.13

$1.19

1-Week Range:

$1.1218

$1.2023

52-Week Range:

$1.00

$5.50

Bionano Genomics Inc Stock (BNGO) Company Profile

Name

Bionano Genomics Inc

Sector

Healthcare (1080)

Industry

Medical Instruments & Supplies (56)

Phone

(858) 888-7600

Address

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA

Employee

Twitter

@bionanogenomics

Next Earnings Date

2026-08-13

Latest SEC Filings

BNGO's Discussions on Twitter

Compare BNGO vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNGO Bionano Genomics Inc	1.18	13.77M	28.74M	-31.60M	-19.30M	-5.0805
ISRG Intuitive Surgical Inc	394.51	141.76B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.40	50.00B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	74.25	35.57B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	224.46	32.78B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.74	31.15B	29.14B	1.07B	1.05B	1.1956

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-10-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Dec-12-22	Resumed	BTIG Research	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Jun-16-21	Initiated	BTIG Research	Buy
Sep-24-20	Initiated	Ladenburg Thalmann	Buy
Apr-08-20	Initiated	Oppenheimer	Outperform

View All

Bionano Genomics Inc Stock (BNGO) Latest News

Aug 14, 2026

Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan

Aug 14, 2026

Aug 13, 2026

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail

Aug 13, 2026

Aug 12, 2026

Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo

Aug 12, 2026

Aug 11, 2026

Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo

Aug 11, 2026

Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria

Aug 11, 2026

Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha

Aug 11, 2026

Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat

Aug 11, 2026